Online citations, reference lists, and bibliographies.

Beneficial Drugs For Liver Diseases.

P. Muriel, Y. Rivera-Espinoza
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Liver diseases are a major problem of worldwide proportions. However, the number of drugs actually used successfully in humans is very small. In this review some of the most promising/studied drugs utilized for liver diseases were chosen and analysed critically from the basic to the clinical point of view. Antiviral agents are not discussed because excellent reviews have appeared on this topic. The compounds/preparations described herein are, alphabetically: colchicine, corticosteroids, curcumin, glycyrrhizin, interferons (for their antifibrotic properties), Liv 52, nitric oxide, resveratrol, silymarin, sulfoadenosylmethionine, and thalidomide. Colchicine and corticosteroids have been studied extensively in animals and humans; most clinical studies suggest that these compounds are not useful in the treatment of liver diseases. Glycyrrhizin is an herbal medicine with several components that has interesting hepatoprotective properties in patients with subacute liver failure but deserves more prospective controlled trials. Interferon has shown interesting antifibrotic properties in animals and humans; prospective studies on their antifibrotic/fibrolytic activity are required. Curcumin, resveratrol and thalidomide are very attractive newly discovered protective and curative compounds on experimental hepatic diseases. Their mechanism of action is associated with the ability to down-regulate NF-kappaB and to decrease pronecrotic and profibrotic cytokines. Unfortunately, clinical studies are lacking. Sulfoadenosylmethionine and silymarin are also promising drugs utilized mainly in cholestasis but the benefits can be expanded if more controlled trials are performed. The future is to carry out controlled prospective double-blind multicenter studies with the newly discovered drugs with proven beneficial effects on animals. Fundamental hepatobiology should also be encouraged.
This paper references
10.1016/0168-8278(89)90004-4
Colchicine prevents D-galactosamine-induced hepatitis.
M. Mourelle (1989)
10.1002/(SICI)1099-1263(199803/04)18:2<143::AID-JAT485>3.0.CO;2-P
Effects of S-adenosyl-L-methionine and interferon-alpha2b on liver damage induced by bile duct ligation in rats.
P. Muriel (1998)
10.1158/0008-5472.CAN-06-3066
Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
M. Li (2007)
10.1002/art.1780110210
Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects.
S. Malawista (1968)
10.1172/JCI112945
Gamma-interferon inhibits collagen synthesis in vivo in the mouse.
R. Granstein (1987)
Hepatoprotective properties of Silybum marianum herbal preparation on ethanol-induced liver damage
M. Wang (1996)
10.1016/J.BBAGEN.2007.02.004
Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress.
Karina Reyes-Gordillo (2007)
10.1007/s10620-005-2942-9
Herbal Medicines for Liver Diseases
R. Dhiman (2005)
10.1016/J.PHYMED.2004.10.003
The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach.
H. F. Huseini (2005)
10.1159/000139485
Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats.
P. Muriel (1997)
10.1159/000139345
Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator.
L. Rodríguez-Fragoso (1995)
10.3748/WJG.V13.I23.3237
Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis.
I. Tasci (2007)
10.1016/J.JSS.2005.01.024
Protective effect of resveratrol against oxidative stress in cholestasis.
C. Ara (2005)
10.1111/J.1600-0676.1993.TB00633.X
Effect of colchicine on acetaminophen-induced liver damage.
P. Muriel (1993)
10.1016/S0027-5107(02)00330-5
Molecular mechanism of the chemopreventive effect of resveratrol.
Z. Dong (2003)
Protective and therapeutic effect of silymarin on the development of latent liver damage.
K. Kropáčová (1998)
10.1016/S0002-9270(02)04182-5
Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane Review
A. Rambaldi (2002)
10.1002/JAT.1249
Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats
E. Chávez (2008)
10.1592/PHCO.27.6.813
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
Wei-Shi Yeh (2007)
10.1016/S0006-2952(99)00002-7
Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages.
T. Wadsworth (1999)
10.1016/J.BCP.2004.06.018
Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat.
Eduardo Fernández-Martínez (2004)
10.1161/01.ATV.19.2.419
Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine.
U. Pendurthi (1999)
10.1016/S0168-8278(01)00289-6
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
P. Mathurin (2002)
10.1002/(SICI)1099-1263(200005/06)20:3<189::AID-JAT632>3.0.CO;2-8
Regulation of nitric oxide synthesis in the liver.
P. Muriel (2000)
10.1056/NEJM199911183412110
Thalidomide--a revival story.
Nishita Raje (1999)
10.1016/S0168-8278(94)80143-6
Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach.
P. Muriel (1994)
10.3748/WJG.V12.I42.6786
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
H. Yoshiji (2006)
10.1096/fj.01-0401rev
S‐Adenosylmethionine: a control switch that regulates liver function
J. A. Mato (2002)
10.1056/NEJM198806303182602
Colchicine in the treatment of cirrhosis of the liver.
D. Kershenobich (1988)
10.1093/carcin/14.5.857
Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells.
J. Liu (1993)
10.1016/S0163-7258(96)00197-0
S-adenosylmethionine synthesis: molecular mechanisms and clinical implications.
J. Mato (1997)
10.1016/0006-2952(73)90113-5
Interaction of some colchicine analogs, vinblastine and podophyllotoxin with rat brain microtubule protein.
M. Zweig (1973)
10.1080/02841860600702076
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma
B. Chuah (2007)
10.1007/S11373-006-9079-5
Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats.
Lee-Won Chong (2006)
10.1016/0168-8278(92)90125-9
Characterization of membrane fraction lipid composition and function of cirrhotic rat liver. Role of S-adenosyl-L-methionine.
P. Muriel (1992)
10.1002/jat.2550100408
Prevention by silymarin of membrane alterations in acute CCl4 liver damage.
P. Muriel (1990)
10.1124/dmd.104.000885
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
T. Walle (2004)
10.1097/01.AIDS.0000247583.38943.95
Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.
J. Barbour (2006)
10.1097/MOG.0b013e328049ddc1
Update on viral hepatitis: 2006
J. Tan (2007)
10.1111/J.1600-0676.1998.TB00120.X
Signal transduction in hepatic stellate cells.
M. Pinzani (1998)
10.1016/S0168-8278(99)80263-3
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
J. A. Mato (1999)
10.1111/J.1478-3231.2006.01261.X
Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
S. Mukherjee (2006)
Treatment of patients with alcoholic liver disease.
F. Zhang (2005)
10.1074/jbc.270.42.24995
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*)
S. Singh (1995)
10.1111/j.1439-0264.2006.00725.x
Effect of α‐Interferon and α‐Tocopherol in Reversing Hepatic Cirrhosis in Rats
T. Mathew (2007)
10.1002/hep.1840380415
Interferon alfa down‐regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice
Y. Inagaki (2003)
10.1093/jnci/6.2.89
Colchicine in the Experimental Chemotherapy of Cancer
R. Ludford (1945)
10.1172/JCI102016
Studies in methionine and sulfur metabolism; the fate of intravenously administered methionine, in normal individuals and in patients with liver damage.
L. Kinsell (1948)
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
S. Pradhan (2006)
10.1111/j.1348-0421.1982.tb00207.x
Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice.
N. Abe (1982)
10.1016/J.HEPRES.2006.02.005
Protective effects of resveratrol against acetaminophen-induced toxicity in mice.
G. Şener (2006)
10.1080/713611034
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
L. Weber (2003)
10.1002/9780470516751.CH6
Some Experimental Models of Liver Damage
P. Muriel (2008)
10.1016/S0742-8413(98)10018-X
Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine.
P. Muriel (1998)
10.1093/JN/131.8.2090
Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice.
K. Okada (2001)
10.1053/JHEP.2001.27445
Complementary and alternative medicine in chronic liver disease
L. Seeff (2001)
10.1097/00042737-200309000-00003
Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rat
P. Muriel (2003)
10.1016/S1567-5769(02)00033-4
Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of glycyrrhizin.
C. Miyaji (2002)
Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes.
M. Goldring (1986)
10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y
Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
M. Miller (1999)
A review of plants used in the treatment of liver disease: part two.
S. Luper (1999)
10.1111/J.1478-3231.2007.01453.X
Prevention of liver cirrhosis in rats by curcumin.
R. Bruck (2007)
10.1111/j.1349-7006.1998.tb00572.x
Inhibitory Effects of Curcumin and Tetrahydrocurcuminoids on the Tumor Promoter‐induced Reactive Oxygen Species Generation in Leukocytes in vitro and in vivo
Y. Nakamura (1998)
10.1002/jat.2550130307
S-adenosyl-L-methionine prevents and reverses erythrocyte membrane alterations in cirrhosis.
P. Muriel (1993)
10.1055/s-2006-960004
Pharmacology of Curcuma longa.
H. P. Ammon (1991)
10.1016/0300-483X(81)90027-5
Metabolism of curcumin--studies with [3H]curcumin.
V. Ravindranath (1981)
Down regulation of tumour necrosis factor activity in experimental hepatitis by a herbal formulation, Liv. 52.
A. Roy (1994)
10.1016/S0024-3205(99)00410-5
Biological effects of resveratrol.
L. Frémont (2000)
10.1111/j.1440-1746.1992.tb00927.x
Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody.
Y. Shiki (1992)
10.1007/BF02915120
Protective effect of silymarin on rat liver injury induced by ischemia
C. G. Wu (1993)
10.1074/jbc.270.25.14867
The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*)
B. Darnay (1995)
10.1002/hep.1840100508
γ‐interferon treatment inhibits collagen deposition in murine schistosomiasis
Mark J. Czaja (1989)
10.1089/JIR.2006.26.301
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes.
G. Giannelli (2006)
Update on viral hepatitis.
A. Narbey (2005)
10.1021/jm9603328
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity.
G. Muller (1996)
10.1093/JAC/DKL170
Does interferon improve portal hypertension?
D. Rincón (2006)
10.1002/JAT.1260
Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat.
H. Rivera (2008)
10.5414/CPP40002
Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
M. Lucena (2002)
10.1111/j.1440-1746.1997.tb00416.x
Effects of glycyrrhizin on immune-mediated cytotoxicity.
M. Yoshikawa (1997)
10.1002/DDR.10022
Effects of thalidomide and 3‐phthalimido‐3‐(3,4‐dimethoxyphenyl)‐propanamide on bile duct obstruction‐induced cirrhosis in the rat
E. Fernández-Martínez (2001)
10.1111/J.1572-0241.1998.00139.X
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
K. Flora (1998)
10.1111/J.1365-2893.2005.00689.X
Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
A. Muir (2006)
Hepatoprotective effects of Liv-52 on ethanol induced liver damage in rats.
R. Sandhir (1999)
10.1038/327524a0
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
R. M. Palmer (1987)
Studies on the hypothetical relationship of thalidomide-induced embryopathy and collagen biosynthesis.
L. Flohe (1981)
A role for the microtubular system in the release of very low density lipoproteins by perfused mouse livers.
Y. le Marchand (1973)
10.1002/jat.2550100409
The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin.
P. Muriel (1990)
Effect of picroliv and silymarin on liver regeneration in rats
Srivastava Savita (1994)
10.1002/ddr.430290109
Effect of silymarin and silybinin on oxygen radicals
Carlos Pascual (1993)
10.1111/j.1472-8206.1989.tb00449.x
PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN
M. Mourelle (1989)
10.1016/0885-4505(86)90124-6
Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice.
S. Giri (1986)
Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.
C. Rao (1995)
10.1016/J.PHRS.2003.11.005
Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
L. Pari (2004)
10.1016/J.LFS.2005.12.007
Multiple biological activities of curcumin: a short review.
R. Maheshwari (2006)
10.1002/JAT.1144
Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice.
M. G. Moreno (2006)
10.1016/S0006-2952(98)00220-2
Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride.
P. Muriel (1998)
10.1096/fj.00-0650rev
Current concepts in the pathogenesis of alcoholic liver injury
H. Tsukamoto (2001)
10.1002/hep.21650
Role of S‐adenosyl‐L‐methionine in liver health and injury
J. Mato (2007)
10.1093/ALCALC/AGH256
Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats.
A. Kasdallah-Grissa (2006)
10.1111/J.1478-3231.2006.01322.X
Prevention of hepatic fibrosis in nonobese diabetic mice: a critical role for interferon-gamma.
T. Mukai (2006)
10.1159/000139163
Effect of alpha-interferon on erythrocyte and hepatocyte plasma membranes derived from cirrhotic rats.
P. Muriel (1994)
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
B. Aggarwal (2004)
10.1111/j.1600-0773.1996.tb00267.x
Effect of colchicine and trimethylcolchicinic acid on CCl4-induced cirrhosis in the rat.
A. Cedillo (1996)
Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
T. Tanaka (1994)
10.1016/S0167-5699(99)01531-5
Thalidomide as an emerging immunotherapeutic agent.
J. Marriott (1999)
10.1016/0006-2952(95)00154-R
Remission of liver fibrosis by interferon-α2b
M. G. Moreno (1995)
10.1006/PHRS.1998.0404
Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages.
Y. Abe (1999)
10.1016/S0024-3205(97)00883-7
Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests.
B. Fauconneau (1997)
10.3109/00365528209182242
Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study.
H. Salmi (1982)
10.1016/S0741-8329(02)00227-6
Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine.
R. Pascale (2002)
10.1002/jat.2550120613
Silymarin protects against paracetamol-induced lipid peroxidation and liver damage.
P. Muriel (1992)
10.1038/modpathol.3800592
Effects of interferon plus ribavirin treatment on NF-κB, TGF-β1, and metalloproteinase activity in chronic hepatitis C
M. Guido (2006)
10.1016/0014-5793(85)80227-1
Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated wth decreaded levels of the procollagen mRNAs(FEBS 2156)
M. L. Stephenson (1985)
10.1111/J.1742-7843.2005.PTO_06.X
Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
P. Muriel (2005)
10.1111/j.1365-2036.2007.03294.x
Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C
M. Šimin (2007)
10.1002/HEP.510270512
Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells
N. Kawada (1998)
10.1002/(SICI)1098-2299(199910)48:2<45::AID-DDR1>3.0.CO;2-K
Role of nitric oxide in the antifibrotic and anticholestatic actions of interferon‐α2b
P. Muriel (1999)
10.1093/carcin/16.10.2493
Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion.
M. Huang (1995)
10.1002/jat.2550150606
Interferon-alpha preserves erythrocyte and hepatocyte ATPase activities from liver damage induced by prolonged bile duct ligation in the rat.
P. Muriel (1995)
10.1016/S0168-8278(01)00190-8
Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood.
L. Spahr (2001)
10.1084/jem.177.6.1675
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
A. Moreira (1993)
Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats.
L. Pari (2005)
The effects of silybin on experimental phalloidine poisoning.
J. Choppin (1978)
10 Curcumin — Biological and Medicinal Properties
B. Aggarwal (2006)
10.1002/9780470516751.CH14
Cytokines in Liver Diseases
P. Muriel (2008)
10.1002/(SICI)1099-1263(199605)16:3<269::AID-JAT346>3.0.CO;2-Y
Comparative study of colchicine and trimethylcolchicinic acid on prolonged bile duct obstruction in the rat.
V. Castro (1996)
Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
L. Jin (2007)
10.1038/sj.bjp.0702357
Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrol
S. H. Tsai (1999)
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
C. Ireson (2001)
10.4049/jimmunol.179.1.708
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice1
C. Tabata (2007)



This paper is referenced by
10.1016/j.nutres.2014.09.005
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Forouzan Faghihzadeh (2014)
10.1186/s12906-015-0655-y
Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity
Neha Singh (2015)
10.5772/INTECHOPEN.83485
Dietary Antioxidants in Experimental Models of Liver Diseases
Sila Appak-Baskoy (2019)
Investigation by Histopathological and TUNEL Method of the Protective Effect of Resveratrol on Carbon Tetrachloride Induced Liver Toxicity in Rats
S. Yıldırım (2017)
10.1186/1758-5996-1-17
Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats
K. Amin (2009)
10.3109/13880209.2014.950387
Hepatoprotective properties of extensively studied medicinal plant active constituents: Possible common mechanisms
H. Farghali (2015)
10.4103/1735-1995.168405
Resveratrol and liver: A systematic review
Forouzan Faghihzadeh (2015)
10.1590/s0004-2803.201900000-62
HEPATOPROTECTIVE EFFICACY OF METHANOLIC EXTRACT OF INDIGOFERA SUFFRUTICOSA (MILL) ON PARACETAMOL-INDUCED LIVER DAMAGE IN MICE.
Izabela Rangel Lima (2019)
10.3390/ijms13079014
Hepatoprotective Effects of Berberis vulgaris L. Extract/β Cyclodextrin on Carbon Tetrachloride–Induced Acute Toxicity in Mice
A. Hermenean (2012)
10.11648/j.ijbse.20170503.12
Clinical Effects of Safflower Pill of Dedu Seven Medicinal Herbs Plus Adefovir Dipivoxil on Liver Fibrosis Resulting from Chronic Viral Hepatitis B
Yi Na (2017)
10.1055/s-0031-1296185
Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats.
Zhi-xing Zhou (2011)
10.1021/jf502632c
Characterization of polysaccharides with antioxidant and hepatoprotective activities from the wild edible mushroom Russula vinosa Lindblad.
Q. Liu (2014)
10.3923/JPT.2011.610.623
Evaluation of Phytochemical, Antioxidant and Hepatoprotective Activity of Tuber of Geodorum laxiflorum Griff
Ram Chandra Besra (2011)
10.1007/s12272-015-0696-2
Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats
Kyoung Ook Cheong (2016)
10.1016/j.etp.2016.12.005
Protective effect of Tritone (Livosone) on oxidative DNA damage and its hepatoprotective potential against various hepatotoxic agent in wistar rats.
Sheetal Kashinath Medhekar (2017)
10.1016/S1995-7645(11)60100-4
Hepatoprotective effect of Woodfordia fruticosa Kurz flowers on diclofenac sodium induced liver toxicity in rats.
Yogesh Baravalia (2011)
10.1007/s00210-016-1263-1
Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress
M. H. Hassan (2016)
10.1016/j.ijbiomac.2014.01.062
In vitro and in vivo antioxidant activity of a fructan from the roots of Arctium lappa L.
Wei Liu (2014)
10.1093/jrr/rrw091
Glycyrrhetinic acid alleviates radiation-induced lung injury in mice
Jinmei Chen (2017)
10.1089/TEN.TEA.2016.0419
A novel drug induced hybrid electrospun PCL - cell derived ECM scaffold for liver tissue engineering
Rhiannon Grant (2017)
10.1016/J.BCAB.2019.101272
GC/MS profile, DNA protectant and hepatoprotective effects of Praecitrullus fistulosus fruit methanol extract.
Chakkere Shivmadhu Madhu (2019)
10.1002/jat.1393
NF-kappaB in liver diseases: a target for drug therapy.
P. Muriel (2009)
10.1142/S0192415X1250036X
Protective effects of HV-P411 complex against D-galactosamine-induced hepatotoxicity in rats.
Jung-Woo Kang (2012)
10.1016/j.apjtm.2017.05.012
Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis.
Naglaa M El-Lakkany (2017)
Development of a cellular predictive model of inflammation associated idiosyncratic drug-induced hepatotoxicity and investigation of its underlying cellular and molecular mechanisms
Léa Saab (2013)
Phytochemical constituents, antioxidant and chemopreventive effects of selected plants against carbon tetrachloride (CCI₄)- inducedhepatic damage in rats
M. D. Shah (2016)
Hepatoprotective Potential of Flavonoid Rich Fraction of Enhydra Fluctuans Against CCl 4-Induced Oxidative Damage in Rats
S. Sannigrahi (2009)
10.11339/JTM.28.139
Glycyrrhizin renders cells resistant to apoptosis induced by human and feline immunodeficiency virus
Hitoshi Sato (2011)
10.3109/19390211.2013.859217
Hepatoprotective Action of Echinophora platyloba DC Leaves Against Acute Toxicity of Acetaminophen in Rats
Esfandiar Heidarian (2014)
10.1016/j.msec.2020.111117
Hepatoprotective effects of silymarin coated gold nanoparticles in experimental cholestasis.
S. Clichici (2020)
10.1271/bbb.90866
Precursor-Directed Biosynthesis of Curcumin Analogs in Escherichia coli
Y. Katsuyama (2010)
10.3892/mmr.2016.6011
Protective effects of Cambodian medicinal plants on tert‑butyl hydroperoxide‑induced hepatotoxicity via Nrf2‑mediated heme oxygenase‑1.
Dong-Sung Lee (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar